Joaquin Duato
Net Worth

Last updated:

What is Joaquin Duato net worth?

The estimated net worth of Mr. Joaquin Duato is at least $39,823,310 as of 13 Feb 2024. He owns shares worth $16,703,310 as insider and has received compensation worth at least $23,120,000 in Johnson & Johnson.

What is the salary of Joaquin Duato?

Mr. Joaquin Duato salary is $2,890,000 per year as Chief Executive Officer & Director in Johnson & Johnson.

How old is Joaquin Duato?

Mr. Joaquin Duato is 62 years old, born in 1963.

What stocks does Joaquin Duato currently own?

As insider, Mr. Joaquin Duato owns shares in one company:

Company Title Shares Price per share Total value
Johnson & Johnson (JNJ) Chief Executive Officer & Director 93,555 $178.54 $16,703,310

What does Johnson & Johnson do?

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

JNJ logo
JNJ
Johnson & Johnson
$178.54

Joaquin Duato insider trading

Johnson & Johnson

Mr. Joaquin Duato has made 2 insider trades between 2017-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 148,538 units of JNJ stock on 17 Jan 2023. As of 13 Feb 2024 he still owns at least 93,555 units of JNJ stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 3,470 N/A N/A
Option
Restricted Share Units 3,470 N/A N/A
Option
Employee Stock Options (Right to Buy) 130,969 $90.44 $11,844,836
Option
Common Stock 130,969 $90.44 $11,844,836
Option
Common Stock 5,225 N/A N/A
Option
Restricted Share Units 5,225 N/A N/A
Option
Restricted Share Units 5,220 N/A N/A
Option
Common Stock 5,220 N/A N/A
Option
Common Stock 148,538 $72.54 $10,774,947
Option
Employee Stock Options (Right to Buy) 148,538 $72.54 $10,774,947
Option
Common Stock 29,714 N/A N/A
Option
Performance Share Units 29,714 N/A N/A
Option
Common Stock 5,424 N/A N/A
Option
Restricted Share Units 5,424 N/A N/A
Option
Employee Stock Options (Right to Buy) 84,423 $65.37 $5,518,732
Option
Common Stock 84,423 $65.37 $5,518,732
Option
Performance Share Units 27,738 N/A N/A
Option
Common Stock 33,021 N/A N/A
Option
Common Stock 33,021 N/A N/A
Option
Performance Share Units 24,561 N/A N/A
Option
Common Stock 105,668 N/A N/A
Option
Performance Share Units 22,624 N/A N/A
Option
Common Stock 22,624 N/A N/A
Option
Restricted Share Units 9,049 N/A N/A
Option
Common Stock 9,049 N/A N/A
Sale
Common Stock 40,000 N/A N/A
Option
Employee Stock Options (Right to Buy) 34,870 N/A N/A
Option
Common Stock 40,000 N/A N/A
Option
Common Stock 24,530 N/A N/A
Option
Performance Share Units 24,530 N/A N/A
Option
Restricted Share Units 9,812 N/A N/A
Option
Common Stock 9,812 N/A N/A
Option
Employee Stock Options (Right to Buy) 50,000 N/A N/A
Option
Common Stock 50,000 N/A N/A
Sale
Common Stock 50,000 N/A N/A
Option
Common Stock 22,298 N/A N/A
Option
Performance Share Units 22,298 N/A N/A
Option
Restricted Share Units 8,919 N/A N/A
Option
Common Stock 8,919 N/A N/A

Johnson & Johnson key executives

Johnson & Johnson executives and other stock owners filed with the SEC: